TissueTech

OverviewSuggest Edit

TissueTech is a biotechnology company that develops regenerative medicine and proprietary technology. It offers amniotic tissue-based products for use in regenerative tissue therapies for ocular surface, musculoskeletal diseases, and disorders. The solutions are applied in ophthalmology and wound care markets.

TypePrivate
Founded2001
HQMiami, FL, US
Websitetissuetech.com
Employee Ratings2.7

Latest Updates

Employees (est.) (Sept 2021)245(-1%)
Cybersecurity ratingAMore

Key People/Management at TissueTech

Amy Tseng

Amy Tseng

President, CEO
Scheffer C.G. Tseng

Scheffer C.G. Tseng

Chief Technology Officer
Devin Buckley

Devin Buckley

Chief Compliance Officer, Corporate Legal Counsel
Michael Cornelius

Michael Cornelius

CFO
Thomas Williamson

Thomas Williamson

Chief Commercial Officer
Show more

TissueTech Office Locations

TissueTech has offices in Miami and Doral
Miami, FL, US (HQ)
7300 Corporate Center Dr #700
Doral, FL, US
8305 NW 27th St
Show all (2)

TissueTech Financials and Metrics

Summary Metrics

Founding Date

2001

TissueTech total Funding

$110 m

TissueTech latest funding size

$82.25 m

Time since last funding

2 years ago

TissueTech investors

TissueTech's latest funding round in June 2019 was reported to be $82.3 m. In total, TissueTech has raised $110 m
Show all financial metrics

TissueTech Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

TissueTech Online and Social Media Presence

Embed Graph

TissueTech Blogs

Inaugural Leadership Summit brings together Key Opinion Leaders from Across the Clinical Spectrum to Share Best Practices on Regenerative Medicine

TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane birth tissue allografts, announced today that the company had completed its first physician leadership summit. The post Inaugural Leadership Summit brings together Key Opinion Leaders from Across the Clinical …

Amniox Launches New Complex Wound Management Campaign in Support of Wound Healing Awareness Month

The Amniox Advantage campaign explores Amniox’s platform technology that has set the standard in successfully treating complex and non-healing wounds Miami, FL – June 10, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue pr…

Amniox Awarded National Agreements with Premier, Inc. and The Resource Group for Birth Tissue Skin Grafting Products

Agreements afford more than 200,000 group purchasing organization members with scaled purchasing options for cryopreserved amniotic membrane and umbilical cord birth tissue products Miami, FL – May 11, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical appli…

Bio-Tissue to Present Webinar in 3-D Showcasing New Treatment Regimen to Successfully Diagnose and Treat Mechanical Dry Eye

In conjunction with National Mechanical Dry Eye Day on May 19, 2021, Neel Desai, M.D. will host a special webinar to raise awareness about the management of Mechanical Dry Eye Miami, FL – May 10, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human bir…

TissueTech Partners with Donate Life America to Raise Public Awareness about the Importance of Tissue Donation

Leader in regenerative medicine joins forces with advocates to spread awareness on the role tissue donation can play in restoring quality of life and improved health Miami, FL – April 19, 2021 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical …

TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain

Investigators will evaluate the dosage and safety of Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord TTAX03 for pain relief and functional improvement of facet joint osteoarthritis in the lumbosacral region Miami, FL – March 8, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc…
Show more

TissueTech Frequently Asked Questions

  • When was TissueTech founded?

    TissueTech was founded in 2001.

  • Who are TissueTech key executives?

    TissueTech's key executives are Amy Tseng, Scheffer C.G. Tseng and Devin Buckley.

  • How many employees does TissueTech have?

    TissueTech has 245 employees.

  • Who are TissueTech competitors?

    Competitors of TissueTech include MiMedx Group, Rebiotix and RayzeBio.

  • Where is TissueTech headquarters?

    TissueTech headquarters is located at 7300 Corporate Center Dr #700, Miami.

  • Where are TissueTech offices?

    TissueTech has offices in Miami and Doral.

  • How many offices does TissueTech have?

    TissueTech has 2 offices.